Hip Replacement Clinical Trials

Clinical trials related to Hip Replacement Procedure

Impact of Dressing Type and Dressing Change Frequency on Surgical Wound Healing Following Primary Total Hip Arthroplasty

Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Surgical wound complications following primary total hip arthroplasty remain a significant clinical challenge despite advances in wound care technologies. The optimal choice of dressing and frequency of dressing changes remain insufficiently investigated, particularly regarding their influence on wound healing and the wound microenvironment. This prospective, randomized, controlled clinical trial aims to evaluate the impact of dressing type and dressing change frequency on surgical wound healing in patients undergoing primary total hip arthroplasty. Ninety patients will be allocated into three treatment groups receiving either a capillary-action dressing system (VACUTEX™) or standard dressings with different dressing change intervals. The study will assess time to complete wound epithelialization, postoperative wound complications, pain intensity, wound temperature, exudate pH, length of hospital stay, and time to suture removal. In addition, the study will investigate the potential role of wound temperature and exudate pH as early indicators of impaired healing and postoperative complications.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 95
Healthy Volunteers: f
View:

• Patients scheduled for primary total hip arthroplasty (THA) Age ≥ 65 years Ability to provide informed consent Patients with closed surgical incision suitable for standard postoperative wound care

Locations
Other Locations
Serbia
Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina
RECRUITING
Novi Sad
Contact Information
Primary
Andrijana Ćorić, MScN
912007d23@mf.uns.ac.rs
+381611810756
Backup
Nemanja Gvozdenović, PhD, Associate Professor
nemanja.gvozdenovic@mf.uns.ac.rs
+381646355614
Time Frame
Start Date: 2026-05-25
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 90
Treatments
Experimental: VACUTEX™ group
Patients receive wound care using the VACUTEX™ capillary action dressing system with dressing changes performed every 4 days until wound closure (suture removal).
Active_comparator: Standard dressing - 3-day change
Patients receive standard wound care using Octenisept® solution with sterile dressing, with dressing changes performed every 3 days until wound closure (suture removal).
Active_comparator: Standard dressing - 2-day change
Patients receive standard wound care using Octenisept® solution with sterile dressing, with dressing changes performed every 2 days until wound closure (suture removal).
Related Therapeutic Areas
Sponsors
Leads: Clinical Center of Vojvodina

This content was sourced from clinicaltrials.gov